211 related articles for article (PubMed ID: 28187440)
1. Interacting partners of FEN1 and its role in the development of anticancer therapeutics.
Kathera C; Zhang J; Janardhan A; Sun H; Ali W; Zhou X; He L; Guo Z
Oncotarget; 2017 Apr; 8(16):27593-27602. PubMed ID: 28187440
[TBL] [Abstract][Full Text] [Related]
2. Fen1 mutations that specifically disrupt its interaction with PCNA cause aneuploidy-associated cancer.
Zheng L; Dai H; Hegde ML; Zhou M; Guo Z; Wu X; Wu J; Su L; Zhong X; Mitra S; Huang Q; Kernstine KH; Pfeifer GP; Shen B
Cell Res; 2011 Jul; 21(7):1052-67. PubMed ID: 21383776
[TBL] [Abstract][Full Text] [Related]
3. FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
He L; Luo L; Zhu H; Yang H; Zhang Y; Wu H; Sun H; Jiang F; Kathera CS; Liu L; Zhuang Z; Chen H; Pan F; Hu Z; Zhang J; Guo Z
Mol Oncol; 2017 Jun; 11(6):640-654. PubMed ID: 28371273
[TBL] [Abstract][Full Text] [Related]
4. Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
He L; Zhang Y; Sun H; Jiang F; Yang H; Wu H; Zhou T; Hu S; Kathera CS; Wang X; Chen H; Li H; Shen B; Zhu Y; Guo Z
EBioMedicine; 2016 Dec; 14():32-43. PubMed ID: 27852524
[TBL] [Abstract][Full Text] [Related]
5. Identification of human flap endonuclease 1 (FEN1) inhibitors using a machine learning based consensus virtual screening.
Deshmukh AL; Chandra S; Singh DK; Siddiqi MI; Banerjee D
Mol Biosyst; 2017 Jul; 13(8):1630-1639. PubMed ID: 28685785
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non-Small-Cell Lung Cancer.
Zhang K; Keymeulen S; Nelson R; Tong TR; Yuan YC; Yun X; Liu Z; Lopez J; Raz DJ; Kim JY
Am J Pathol; 2018 Jan; 188(1):242-251. PubMed ID: 29037854
[TBL] [Abstract][Full Text] [Related]
7. The FEN1 L209P mutation interferes with long-patch base excision repair and induces cellular transformation.
Sun H; He L; Wu H; Pan F; Wu X; Zhao J; Hu Z; Sekhar C; Li H; Zheng L; Chen H; Shen BH; Guo Z
Oncogene; 2017 Jan; 36(2):194-207. PubMed ID: 27270424
[TBL] [Abstract][Full Text] [Related]
8. FEN1 mediates miR-200a methylation and promotes breast cancer cell growth
Zeng X; Qu X; Zhao C; Xu L; Hou K; Liu Y; Zhang N; Feng J; Shi S; Zhang L; Xiao J; Guo Z; Teng Y; Che X
FASEB J; 2019 Oct; 33(10):10717-10730. PubMed ID: 31266372
[TBL] [Abstract][Full Text] [Related]
9. Small-Molecule Inhibitors Targeting FEN1 for Cancer Therapy.
Yang F; Hu Z; Guo Z
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883563
[TBL] [Abstract][Full Text] [Related]
10. Mapping the FEN1 interaction domain with hTERT.
Sampathi S; Chai W
Biochem Biophys Res Commun; 2011 Apr; 407(1):34-8. PubMed ID: 21345332
[TBL] [Abstract][Full Text] [Related]
11. Adenomatous polyposis coli interacts with flap endonuclease 1 to block its nuclear entry and function.
Jaiswal AS; Armas ML; Izumi T; Strauss PR; Narayan S
Neoplasia; 2012 Jun; 14(6):495-508. PubMed ID: 22787431
[TBL] [Abstract][Full Text] [Related]
12. Interaction between APC and Fen1 during breast carcinogenesis.
Narayan S; Jaiswal AS; Law BK; Kamal MA; Sharma AK; Hromas RA
DNA Repair (Amst); 2016 May; 41():54-62. PubMed ID: 27088617
[TBL] [Abstract][Full Text] [Related]
13. Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genes.
Ward TA; McHugh PJ; Durant ST
PLoS One; 2017; 12(6):e0179278. PubMed ID: 28628639
[TBL] [Abstract][Full Text] [Related]
14. YY1 suppresses FEN1 over-expression and drug resistance in breast cancer.
Wang J; Zhou L; Li Z; Zhang T; Liu W; Liu Z; Yuan YC; Su F; Xu L; Wang Y; Zhou X; Xu H; Hua Y; Wang YJ; Zheng L; Teng YE; Shen B
BMC Cancer; 2015 Feb; 15():50. PubMed ID: 25885449
[TBL] [Abstract][Full Text] [Related]
15. Versatile Types of DNA-Based Nanobiosensors for Specific Detection of Cancer Biomarker FEN1 in Living Cells and Cell-Free Systems.
Zhang H; Ba S; Mahajan D; Lee JY; Ye R; Shao F; Lu L; Li T
Nano Lett; 2018 Nov; 18(11):7383-7388. PubMed ID: 30336066
[TBL] [Abstract][Full Text] [Related]
16. Functional regulation of FEN1 nuclease and its link to cancer.
Zheng L; Jia J; Finger LD; Guo Z; Zer C; Shen B
Nucleic Acids Res; 2011 Feb; 39(3):781-94. PubMed ID: 20929870
[TBL] [Abstract][Full Text] [Related]
17. Flap endonuclease 1: a central component of DNA metabolism.
Liu Y; Kao HI; Bambara RA
Annu Rev Biochem; 2004; 73():589-615. PubMed ID: 15189154
[TBL] [Abstract][Full Text] [Related]
18. Functional regulation of the structure-specific endonuclease FEN1 by the human cytomegalovirus protein IE1 suggests a role for the re-initiation of stalled viral replication forks.
Schilling EM; Scherer M; Rothemund F; Stamminger T
PLoS Pathog; 2021 Mar; 17(3):e1009460. PubMed ID: 33770148
[TBL] [Abstract][Full Text] [Related]
19. [Flap endonuclease-1 and its role in the processes of DNA metabolism in eucaryotic cells].
Nazarkina ZhK; Lavrik OI; Khodyreva SN
Mol Biol (Mosk); 2008; 42(3):405-21. PubMed ID: 18702299
[TBL] [Abstract][Full Text] [Related]
20. Investigation of human flap structure-specific endonuclease 1 (FEN1) activity on primer-template models and exploration of a substrate-based FEN1 inhibitor.
Ba S; Zhang H; Lee JY; Wu H; Ye R; Huang D; Li T
Bioorg Med Chem; 2016 May; 24(9):1988-92. PubMed ID: 27020684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]